-
Loading metrics
Open Access
Peer-reviewed
Research Article
Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis
-
Richard B. Warren ,
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
¶‡ First author.
Affiliations Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
⨯ -
Hamish J. A. Hunter,
Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliations Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom, NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, Medicines Evaluation Unit, Manchester, United Kingdom
⨯ -
Kim A. Papp,
Roles Conceptualization, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliations Alliance Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada, Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
⨯ -
Kenneth B. Gordon,
Roles Conceptualization, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Dermatology, Medical College of Wisconsin, Wauwatosa, Wisconsin, United States of America
⨯ -
Meina T. Tang,
Roles Conceptualization, Data curation, Formal analysis, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Jeffrey V. Enejosa,
Roles Conceptualization, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Kuan-Chieh Huang,
Roles Data curation, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Debasish Raha,
Roles Data curation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Hashini M. Batugedara,
Roles Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Craig Skinner,
Roles Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Philip A. Kobel,
Roles Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Peter M. Rademacher,
Roles Investigation, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Nico Ghilardi ,
Roles Conceptualization, Data curation, Formal analysis, Methodology, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing
* E-mail: nico.ghilardi@lilly.com
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
Paul Fatheree,
Roles Project administration, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ -
John R. Jacobsen,
Roles Data curation, Formal analysis, Funding acquisition, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ - [ ... ],
-
Timothy T. Lu
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliation DICE Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, South San Francisco, California, United States of America
⨯ - [ view all ]
- [ view less ]
Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis
- Richard B. Warren,
- Hamish J. A. Hunter,
- Kim A. Papp,
- Kenneth B. Gordon,
- Meina T. Tang,
- Jeffrey V. Enejosa,
- Kuan-Chieh Huang,
- Debasish Raha,
- Hashini M. Batugedara,
- Craig Skinner
- Published: January 23, 2026
- https://doi.org/10.1371/journal.pone.0341049